The CRISPR tool has attracted worldwide attention from the R&D industry in regards to its capabilities for gene editing. CRISPR alongside the use of the Cas9 protein enables the ability to target...
Our Pharma IQ content team put together this great informational interview about the emerging technologies that is CRISPR and CAS9. Check out all the information you need to know!
The money being spent in gene editing is going straight towards CRISPR, but which big Pharma companies are spending and what are they spending their money on? We know that millions are being poured into this dynamic research, but this infographic will tell you where and how!
We spoke to Patrick Ansems, EMEAI, Director at PerkinElmer who said "Biology is a strategic area for us as big data analytics can play an important role in unlocking insights from complex biological data. For example, if you look at transitional science, it's all about aggregating the data together to understand the disease."